Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Saved in:
| Title: | Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS). |
|---|---|
| Authors: | Sparber-Sauer M; Klinikum Stuttgart - Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pediatrics 5 (Oncology, Hematology, Immunology), Stuttgart, Germany., Stegmaier S; Klinikum Stuttgart - Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pediatrics 5 (Oncology, Hematology, Immunology), Stuttgart, Germany., Vokuhl C; Section of Pediatric Pathology, Department of Pathology, Kiel Pediatric Tumor Registry, Kiel, Germany., Seitz G; Department of Pediatric Surgery, University Children's Hospital Marburg, Marburg, Germany., von Kalle T; Klinikum Stuttgart - Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Olgahospital, Institute of Radiology, Stuttgart, Germany., Scheer M; Klinikum Stuttgart - Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pediatrics 5 (Oncology, Hematology, Immunology), Stuttgart, Germany., Münter M; Klinikum Stuttgart, Institute of Radiotherapy, Stuttgart, Germany., Bielack SS; Klinikum Stuttgart - Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pediatrics 5 (Oncology, Hematology, Immunology), Stuttgart, Germany.; Department of Pediatric Hematology and Oncology, University of Muenster, Muenster, Germany., Weclawek-Tompol J; Department of Pediatric Hematology/Oncology and BMT, University of Wroclaw, Wroclaw, Poland., Ladenstein R; Pediatric Oncology, St. Anna Kinderspital, Wien, Austria., Niggli F; Department of Pediatric Oncology, University of Zurich, Zurich, Switzerland., Ljungman G; Department of Women's and Children's Health, Children's University Hospital, University of Uppsala, Uppsala, Sweden., Fuchs J; Department of Pediatric Surgery and Urology, University Children's Hospital, Tuebingen, Germany., Hettmer S; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Koscielniak E; Klinikum Stuttgart - Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pediatrics 5 (Oncology, Hematology, Immunology), Stuttgart, Germany.; Department of Pediatric Hematology and Oncology, Children's Hospital, Tuebingen, Germany., Klingebiel T; Department for Children and Adolescents, University Hospital of Frankfurt, Frankfurt/M., Germany. |
| Corporate Authors: | CWS Study Group |
| Source: | Pediatric blood & cancer [Pediatr Blood Cancer] 2019 Jun; Vol. 66 (6), pp. e27652. Date of Electronic Publication: 2019 Feb 14. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
